Skip to main content

Mckesson Medical-Surgical Inc. Corporate Office

5 ongoing recalls and 152 historical records

Based on the official records currently available to Public Health Trace, 5 recalls naming Mckesson Medical-Surgical Inc. Corporate Office are currently shown as ongoing. The other 152 records below are historical.

Public Health Trace has 157 recalls naming Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm, republished from official FDA and USDA sources.

Recall records - 157 total

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
202290
20245
20255
Download CSV

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Tetracaine Hydrochloride Ophthalmic Solution, 0.5%, 4 mL bottle, Rx only, MFG: Alcon Surgical Inc., NDC 0065-0741-14

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Geodon for injection (ziprasidone mesylate), 20 mg/mL, 1 mL single dose vial, Rx only, MFG: Viatris, NDC 0049-3920-83

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-522-69

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Metoprolol tablets 50 mg, 100-count botte, Rx only, MFG: Sun Pharmaceuticals, NDC 57664-0477-52

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Pilocarpine HCL Ophthalmic Solution, USP 2%, 15 mL, Rx only, MFG: Somerset Therapeutics, Inc., NDC 7006919101

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Tropicamide Ophthalmic Solution, USP 1%, 3 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 6131435502

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP, sterile, 0.1%, 10 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 6131462810

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Triamcinolone Acetonide cream, USP, 0.1% ,15 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0004-15

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Prednisolone Acetate Ophthalmic Suspension, USP 1%, 5 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 61314-637-05

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Pantoprazole Sodium for Injection, 40 mg/vial, 10 single-dose vials, Rx only, MFG: Sandoz Pharma, NDC 0781-3232-95

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Ondansetron HCL, Tab 8 mg filmcoated, 30-count bottle, Rx only, MFG: Sandoz Pharma, NDC 65862-188-30

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: November 30, 2023Historical recordClass II

Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, 3.5 g tube, Rx only MFG: Sandoz, NDC 61314-631-36

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Published
June 15, 2022
Distribution
Nationwide

View recall →

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name Mckesson Medical-Surgical Inc. Corporate Office as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.